Hartke Lopa P, Gilkeson Robert C, O'Riordan Mary Ann, Siwik Ernest S
Department of Internal Medicine, Case University/University Hospitals of Cleveland/Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
Congenit Heart Dis. 2006 Sep;1(5):192-201. doi: 10.1111/j.1747-0803.2006.00035.x.
Gadolinium-enhanced cardiac magnetic resonance imaging has been used to show myocardial fibrosis, a finding that appears as late gadolinium enhancement. Its role in the evaluation of right ventricular fibrosis in congenital heart disease is unclear. The purpose of this study was to demonstrate late gadolinium enhancement of the right ventricle in adult and adolescent congenital heart disease and to investigate the relationship between this enhancement and clinical and pathophysiological data.
In total, 24 patients, 16 patients with congenital heart disease and right ventricular loading conditions and 8 controls, underwent gadolinium-enhanced viability imaging. Diagnoses varied and included repaired, palliated, and unrepaired lesions. The presence and extent of right ventricular late gadolinium enhancement was compared with patient clinical and hemodynamic data. Exact Wilcoxon tests, Fisher's exact tests, and Spearman's rank correlation were used to compare variables.
Nine of 16 patients (56%) were found to have right ventricular late gadolinium enhancement, ranging from 5% to 80% of right ventricular myocardium affected (mean 36.1%, SD 29.7). The combination of right ventricular systolic pressure >or=98 mm Hg and systemic oxygen saturation <or=93% strongly suggested the presence of right ventricular late gadolinium enhancement (positive predictive value 100%), but no single variable or combination of variables could reliably predict its absence (negative predictive values <or=75%). Extent of right ventricular late gadolinium enhancement did not correlate with degree of either hypoxia or right ventricular hypertension.
Gadolinium-enhanced cardiac magnetic resonance demonstrates right ventricular late gadolinium enhancement in some patients with congenital heart disease and right ventricular loading conditions. Clinical variables were associated with the presence of fibrosis but did not reliably predict severity. Myocardial preservation is likely a multifactorial process that may affect the right and left ventricles differently.
钆增强心脏磁共振成像已被用于显示心肌纤维化,这一发现表现为钆延迟强化。其在先天性心脏病右心室纤维化评估中的作用尚不清楚。本研究的目的是证明成人和青少年先天性心脏病患者右心室的钆延迟强化,并研究这种强化与临床和病理生理数据之间的关系。
总共24例患者,其中16例患有先天性心脏病且存在右心室负荷情况,8例为对照组,均接受了钆增强存活成像检查。诊断各异,包括修复、姑息治疗和未修复的病变。将右心室钆延迟强化的存在情况和范围与患者的临床及血流动力学数据进行比较。采用精确Wilcoxon检验、Fisher精确检验和Spearman秩相关分析来比较变量。
16例患者中有9例(56%)被发现存在右心室钆延迟强化,受影响的右心室心肌范围为5%至80%(平均36.1%,标准差29.7)。右心室收缩压≥98 mmHg且全身氧饱和度≤93%强烈提示存在右心室钆延迟强化(阳性预测值100%),但没有单一变量或变量组合能够可靠地预测其不存在(阴性预测值≤75%)。右心室钆延迟强化的程度与缺氧程度或右心室高压程度均无相关性。
钆增强心脏磁共振成像显示,部分患有先天性心脏病且存在右心室负荷情况的患者存在右心室钆延迟强化。临床变量与纤维化的存在相关,但不能可靠地预测其严重程度。心肌保护可能是一个多因素过程,对左右心室的影响可能不同。